By Margot Sanger-Katz and Rebecca Robbins The Trump administration on Friday rejected ... not ruled out coverage and “may consider future policy options” for the drugs. Medicare, the ...

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's ...

The conflict between Harvard and the Trump regime poses fundamental issues of democratic rights, including academic freedom.

Trump and Oz have used the pretext of fighting fraud as an excuse to cut Medicare coverage. During his Senate ... life-threatening delays and outright rejections of treatment.

The Trump administration canceled a Biden-era plan on Friday that would have made Ozempic and other weight-loss drugs ...

But the retribution effort is far more expansive, efficient and creative than that — and less reliant on the justice system.

The Trump administration did stick with a Biden administration policy change ... have boosted payments to Medicare Advantage ...